Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Maclean's on MSN
The end of fat
Diet drugs like Ozempic and Mounjaro are about to get a whole lot cheaper. Are we ready for a world where anyone can be thin?
一些您可能无法访问的结果已被隐去。
显示无法访问的结果